G01N 2333/91255
Dna-directed rna polymerase
Official title: DNA-directed RNA polymerase (2.7.7.6)
G01N2333/91255 (Dna-directed rna polymerase) appears on 6 US grants and 12 published applications in this corpus.
Search patents in G01N- Granted patents
- 6
- Published applications
- 12
- Assignees
- 10
- Inventors
- 36
- Latest grant
- 12 Sep 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 2 |
| 2015 | 1 | 0 |
| 2016 | 1 | 2 |
| 2017 | 2 | 1 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 1 |
| 2023 | 1 | 0 |
| 2024 | 0 | 3 |
| 2025 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Inhibitor of RNA polymerase II12 Sep 2023US 11,752,192 B2
- Antibacterial agents: salinamide derivatives7 Nov 2017US 9,809,626 B2Rutgers, The State University of New Jersey
- Antibacterial agents: salinamide derivatives28 Mar 2017US 9,605,028 B2Rutgers, The State University of New Jersey
- Compositions and methods for the treatment of norovirus infection29 Mar 2016US 9,296,719 B2Alios BioPharma, Inc.
- Antibacterial agents: salinamide derivatives29 Dec 2015US 9,221,880 B2Rutgers, The State University of New Jersey
- Compositions and methods relating to engineered rna polymerases with capping enzymes11 Sep 2025US 2025/0283060 A1Board of Regents, The University of Texas System
- Mutant brd4 polypeptides and methods of use thereof26 Dec 2024US 2024/0425555 A1
- Isothermal gene amplification method, gene detection method, virus detection method, and kit used therefor18 Jul 2024US 2024/0240266 A1BioSeeds Corporation
- Methods for modulating a src-1 condensate18 Apr 2024US 2024/0125768 A1Etern Biopharma (Shanghai) Co., Ltd.
- An enzymatic assay to measure long-term adherence to pre exposure prophylaxis and antiretroviral therapy29 Sep 2022US 2022/0307066 A1The General Hospital Corporation
Most cited
By later US patents
- High-throughput screening assays for modulators of primase activity23US 6,043,038 ATularik Inc. · 2000
- Antibacterial agents: salinamide derivatives2US 9,221,880 B2Rutgers, The State University of New Jersey · 2015
- Antibacterial agents: salinamide derivatives2US 9,605,028 B2Rutgers, The State University of New Jersey · 2017
- Compositions and methods for the treatment of norovirus infection1US 9,296,719 B2Alios BioPharma, Inc. · 2016